non-small cell lung cancer
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
Rapid and dramatic radiographic and clinical response to an <span class="gene" id="21102269-0-60-63">ALK</span> inhibitor (crizotinib, PF02341066) in an <span class="gene" id="21102269-0-105-108">ALK</span> translocation-positive patient with <span class="disease" id="21102269-0-145-171">non-small cell lung cancer</span>.